Melissa Putman, MD
Enriched profileAssociate Professor of Medicine at Harvard Medical School · Harvard Medical School
Melissa Putman is Associate Professor of Medicine at Harvard Medical School at Harvard Medical School. OpenAlex indexes 131 publications with 1,916 citations (h-index 24); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.
Data verified 21 Oct 2026
Overview
Updated 22 Oct 2026
Melissa Putman, MD, is Associate Professor of Medicine at Harvard Medical School. The public record shows 131 publications with 1,916 citations (h-index 24), centered on Cystic Fibrosis Research Advances, Diabetes Management and Research, Bone health and osteoporosis research. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 5 companies, 3 NIH-funded awards (2015–2026).
- Most recent indexed publication: 2026 · Diabetologia
- Top research focus: Cystic Fibrosis Research Advances
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 40.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinicaltrials.gov ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 22 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment
Sponsor: Massachusetts General Hospital
- Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
Sponsor: University of Colorado, Denver
- Bionic Pancreas in CFRD
Sponsor: Jaeb Center for Health Research
Industry payments
Updated 22 Oct 2026
5 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20255 payments$12,127openpaymentsdata.cms.gov ↗
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20254 payments
- Dexcom, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
64.7%l-Thyroxine26.5%Levothyroxine Sodium100%Part D<11 patientsAntihypoglycemic Agent19.1%Gvoke Hypopen 2-Pack100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
19.1%Insulin Analog19.1%Lantus100%Part D<11 patientsCardiovascular
16.2%Thiazide diuretic16.2%Hydrochlorothiazide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 22 Oct 2026
3 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Clinical Studies Investigating Use of the Bionic Pancreas in Pregnancy
Massachusetts General Hospital
FY2026$708,133R01DK140780 - Clinical Studies Investigating Use of the Bionic Pancreas in Pregnancy
Massachusetts General Hospital
FY2025$725,192R01DK140780 - Clinical Studies Investigating Use of the Bionic Pancreas in Pregnancy
Massachusetts General Hospital
FY2024$725,628R01DK140780
Congress activity
Updated 22 Oct 2026
12 congress contributions (2020–2026) across ADA, ENDO per OpenAlex. The most recent:
- 1947-P: Assessing Advanced Glycation Endproducts Using a Wearable Health Monitoring Device
ADA Scientific Sessions
ADA2026Co-authorPoster - 2270-P: Glucose Dynamic Instability on Continuous Glucose Monitoring Discriminates Cystic Fibrosis–Related Diabetes
ADA Scientific Sessions
ADA2026Co-authorPoster - 2962-LB: CGM Metrics and Cardiovascular and Mortality Outcomes in Type 2 Diabetes: Data from the GRADE-CGM Substudy
ADA Scientific Sessions
ADA2026Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 22 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP Systems.
Journal of diabetes science and technology
Review2025 - Accuracy of continuous glucose monitoring in the hospital setting: an observational study.
Diabetologia
Article2024 - Advancing our understanding of cystic fibrosis-related bone disease.
Journal of bone and mineral research
Comment2024
Most-cited works
by citation count (OpenAlex)- 01Two-Year Changes in Bone Density After Roux-en-Y Gastric Bypass SurgeryArticle148 citations2015
- 02
- 03Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19Article133 citations2020
- 04Defects in cortical microarchitecture among African-American women with type 2 diabetesArticle131 citations2014
- 05
Network
Updated 22 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 22 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
massgeneralbrigham.org/en/doctors/p/melissa-putman-3001311
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 22 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
- Board Certified in Endocrinology
Diabetes and Metabolism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Christos Mantzoros, MD
Harvard Medical School
Aneesh Singhal, MD
Harvard Medical School
William Sauer, MD
Harvard Medical School
Aleksandar Videnovic, MD
Harvard Medical School
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH